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Abstract
Background: Progesterone is thought to mediate im-
mune modulator effects by regulating uterine respon-
siveness. The aim of the study was to clarify the effect of
transferrin and glycodelin A (former name PP14) as sialyl
Lewis X-expressing glycoproteins on the release of pro-
gesterone by trophoblast cells in vitro. Methods: Cyto-
trophoblast cells were prepared from human term pla-
centas by standard dispersion of villous tissue followed
by a Percoll gradient centrifugation step. Trophoblasts
were incubated with varying concentrations (50–300 Ìg/
ml) of human amniotic fluid- and serum-transferrin as
well as with glycodelin A. Culture supernatants were
assayed for progesterone, human chorionic gonadotro-
pin (hCG) and cortisol by enzyme immunometric meth-
ods. Results: The release of progesterone is increased in
amniotic fluid transferrin- and glycodelin A-treated tro-
phoblast cell cultures compared to untreated trophoblast
cells. There is no relation between transferrin and the
hCG or cortisol production of trophoblast cells. Conclu-
sion: The results suggest that sialyl Lewis carbohydrate
antigen-expressing amniotic fluid glycoproteins modu-
late the endocrine function of trophoblasts in culture by
upregulating progesterone production.
Copyright © 2004 S. Karger AG, Basel
Introduction
During pregnancy the immune response of the mother
against certain antigens is reduced [1, 2]. Progesterone is
one of a variety of molecules that regulate uterine im-
mune responsiveness [3, 4] by inhibiting the inflammato-
ry response [5]. The suppression of mixed lymphocyte
culture responses by progesterone has also been described
[6]. Due to its lipid solubility, progesterone incorporates
into the lymphocyte plasma membrane interfering with
membrane dynamics [7]. This promotes a locally sup-
pressed activity at the maternal-fetal frontier [8].
In most mammals, progesterone production is initially
located in the corpus luteum of the ovary, shifting to the
trophoblast as pregnancy proceeds. Progesterone biosyn-
thesis in the human placenta is regulated by a variety of
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hormones. Progesterone synthesis is also regulated by
estradiol-17ß and autoregulated by progesterone itself [4].
Feinberg et al. [8] showed that progesterone production
was significantly stimulated by interleukin (IL)-1·, IL-1ß
and tumor necrosis factor-· (TNF-·) in chorion carcino-
ma cells. In addition, progesterone also plays a role in the
maintenance of pregnancy, and administration of proges-
terone is able to prevent preterm delivery [9, 10].
During gestation, the fetus requires large amounts of
iron. The major iron source is maternal serum transferrin
[11, 12]. Transferrin-dependent iron transfer is mediated
by transferrin receptors, which are present on the mater-
nal-facing plasma membrane and on the fetal-facing basal
plasma membrane of placental syncytiotrophoblasts [13,
14].
Glycodelin, previously known as placental protein 14
(PP14), is an approximately 28-kD glycoprotein with a
unique carbohydrate configuration, consistent with sialy-
lated LacdiNAc structures that are very unusual for mam-
mals [15]. Glycodelin is a major reproductive glycopro-
tein with several functions in cell recognition and differ-
entiation [16]. Under physiological conditions glycodelin
is mainly synthesized in secretory endometrial glands [17,
18] and gestational decidua [19]. Although the precise
function of glycodelin A has still not been elucidated, it
can inhibit the activity of natural killer (NK) cells [20] and
therefore play a major role during implantation and the
early development of the fetal-placental unit. Interesting-
ly, glycodelin A levels rise rapidly in early pregnancy, with
the highest concentrations being found in the decidua
between the 6th and 12th week of gestation [21], suggest-
ing important function in early pregnancy.
In the present study, we investigated the influence of
the human amniotic fluid glycoprotein transferrin, hu-
man holo-serum transferrin and apo-serum transferrin
and glycodelin A on progesterone release of trophoblast
cells in vitro.
Materials and Methods
Purification of Transferrin from Amniotic Fluid (hAFT)
Human amniotic fluid transferrin (hAFT) was purified as pre-
viously published [22]. Briefly, amniotic fluid was dialyzed and frac-
tionated on a DEAE-Sepharose (Amersham Biosciences, Uppsala,
Sweden). Transferrin-containing fractions were further purified on
Superdex 75 (Amersham Biosciences). Subsequently, transferrin-
containing material was applied to a protein A column (Amersham
Biosciences) to remove the remaining IgG. Monoclonal antibodies
directed against human chorionic gonadotropin (hCG; Dianova,
Hamburg, Germany) were coupled to CNBr-Sepharose 4B (Amers-
ham Biosciences) to remove traces of hCG. Transferrin-containing
material was applied to the column; the main fraction containing
pure amniotic fluid transferrin was concentrated by ultrafiltration.
The purity was checked by SDS-PAGE and N-terminal amino acid
analysis. Quantification of the isolated transferrin was performed on
a VITROS 250 analyzer (Ortho Clinical Diagnostics GmbH, Neckar-
gemünd, Germany).
Purification of Glycodelin A from Amniotic Fluid
Glycodelin A was purified as recently published [23]. Briefly
human amniotic fluid was dialyzed and fractionated on DEAE-
Sepharose (Amersham Biosciences). Glycodelin A was further puri-
fied on octyl-Sepharose Cl-4B (Amersham Biosciences). Final purifi-
cation was achieved by hydrophobic interaction chromatography on
Resource-Phe (Amersham Biosciences). Glycodelin A-containing
fractions were concentrated by ultrafiltration.
Culture of Trophoblasts
Cytotrophoblast cells were isolated from term human placentas
following spontaneous delivery or planned cesarean section and were
processed according to Kliman et al. [24] with slight modifications
[23]. Briefly, villous tissue was minced and transferred to a trypsin/
DNAse I mixture (142.4 mg trypsin and 5 mg DNAse I; Sigma-
Aldrich, Taufkirchen, Germany). The remaining tissue fragments
were digested twice in trypsin/DNAse I solution (71.2 mg trypsin and
5 mg DNAse I; Sigma-Aldrich). The cell suspensions obtained by the
three digestion steps were pooled and loaded on a preformed Percoll
(Amersham Biosciences) gradient. The density zone containing tro-
phoblast cells was removed. The trophoblast identity of the isolated
cells was confirmed by their ability to produce specific hormones
(hCG, hPL and progesterone) and by immunostaining with an anti-
cytokeratin antibody (anti-cytokeratin AE1/AE3; Roche, Mannheim,
Germany). Viability of trophoblast cells was tested using a trypan
blue exclusion assay (Sigma-Aldrich, Munich, Germany).
Treatment of Trophoblast Cultures with hAFT, Serum
Transferrin and Glycodelin A
Trophoblasts were adjusted to a cell concentration of 1 ! 106
cells/ml in RPMI 1640 culture medium supplemented with 10%
fetal calf serum and gentamycin (200 Ìg/ml) and incubated in the
presence of varying concentrations (50–250 Ìg/ml) of amnion
transferrin, varying concentrations (100–300 Ìg/ml) of human
holo- and apo-serum transferrin (Sigma-Aldrich) and varying con-
centrations (50–250 Ìg/ml) of glycodelin A. The effect of the glyco-
proteins on the secretion of progesterone was studied by simulta-
neously comparing the kinetics of progesterone release of untreated
(controls) and glycoprotein-stimulated trophoblast cell cultures. At
designated times, aliquots of the culture media were removed, fro-
zen at –20 °C and replaced with fresh medium. Cells were cultured
for up to 64 h.
Identification of Secreted Hormones
The analyzer SR1 from BioChemImmunoSystems GmbH deter-
mined the secretion of progesterone. Samples were diluted 1:3 with
hormone-free diluents because of the intensively colored culture
medium. The sensitivity and the intra-assay coefficient of variation
of progesterone EIA (!6.4 nmol/l and 6.8% at a medium value of
11.5 nmol/l; 5.4% at 65.6 nmol/l, respectively) demonstrate the accu-
racy of the applied methods.
Progesterone Stimulation in Trophoblast
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Fig. 1. Effect of human amnion fluid trans-
ferrin (hAFT) and glycodelin A on the pro-
gesterone production of trophoblast cells in
vitro. Data (mean B SD) represent proges-
terone concentration in aliquots of the cul-
ture media at designated times, n = 4 for
each group. Differences between the controls
and stimulated cultures are significant for
cultures stimulated with 50, 100 and 250 Ìg/
ml hAFT (p ! 0.002, 0.002 and 0.004) and
cultures stimulated with 100 and 250 Ìg/ml
glycodelin A (p ! 0.001, 0.001).
Statistical Analysis
The Wilcoxon’s signed rank tests for paired samples was used to
compare the means. Statistical computerization of the analysis uti-
lized the SPSS software package (SPSS, Chicago, Ill., USA). p ! 0.05
was considered statistically significant.
Results
Stimulation of Progesterone Production by hAFT and
Glycodelin A
Analysis of progesterone in stimulated and unstimulat-
ed cell cultures revealed that hAFT- and glycodelin A-stim-
ulated trophoblast cells showed a higher secretion of pro-
gesterone compared to unstimulated cells over a cultivation
period of 48 h (fig. 1). There was a significant difference
between the progesterone production of stimulated and
unstimulated cell cultures (p ! 0.002 for 50 Ìg hAFT, p !
0.002 for 100 Ìg hAFT and p ! 0.004 for 250 Ìg hAFT). The
stimulation effect of hAFT is dose-dependent. Cells stimu-
lated with 250 Ìg/ml hAFT showed the highest stimulation
effects compared to 100 and 50 Ìg/ml hAFT-stimulated
cells. The relative stimulation with 50 Ìg/ml hAFT was
112.4%, with 100 Ìg/ml hAFT 119.4% and with 250 Ìg/ml
hAFT 122% compared to unstimulated controls. The rela-
tive progesterone production of trophoblast cells stimulat-
ed by 50 Ìg/ml glycodelin A was not significantly different
from unstimulated controls (p 1 0.4). In trophoblast cells
stimulated with 100 and 250 Ìg/ml glycodelin A, the pro-
gesterone production was elevated to 185.5 and 240.8%,
respectively. These differences between stimulated cells
and controls were significant (p ! 0.001 and p ! 0.001).
No Stimulation of Progesterone Production by Holo-
and Apo-Serum Transferrin
Over the cultivation period of 48 h, trophoblast cells
from two human term placentas stimulated with 100 and
300 Ìg/ml of apo- and holo-serum transferrin did not
show an increase in progesterone production as compared
to unstimulated controls (p 1 0.7; fig. 2). In addition, we
found that neither of the tested transferrins had an effect
on the hCG or cortisol release of trophoblast cells (data
not shown).
Discussion
At term, the human placenta produces approximately
300 mg of progesterone and about 100 mg of estrogens per
day [25]. Progesterone facilitates the maintenance of preg-
nancy through a multitude of mechanisms, e.g. by acting
on the myometrium and the uterine cervix. There is evi-
dence that progesterone has immunosuppressive effects
and regulates the cytokine network in the uterus [26].
Interestingly, IL-1·, IL-1ß and TNF-· can significantly
stimulate the progesterone production of the trophoblast
tumor cell line JEG-3 [8]. However, in primary placental
cells IL-1ß had no effect on progesterone production [27].
Studies by Shanker and Rao [28] showed that incubation
of cultured trophoblast cells with estradiol-17ß increased
progesterone production. The addition of the aromatase
inhibitor CGS 16949 A and the estrogen receptor antago-
nist ICI 182780 inhibited progesterone production. RU
486 and ZK 98299, which are progesterone receptor
210 Gynecol Obstet Invest 2004;58:207–211 Jeschke/Mylonas/Richter/Streu/Müller/
Briese/Friese
Fig. 2. Effect of human holo- and apo-serum
transferrin on progesterone production in
trophoblast cells. Trophoblast cells stimulat-
ed with 100 and 300 Ìg/ml of holo- or apo-
serum transferrin showed no significantly
different progesterone secretion compared
to unstimulated controls (p 1 0.7).
antagonists, also significantly modulated progesterone
synthesis. Therefore, progesterone synthesis in the human
placenta is regulated by estradiol-17ß and autoregulated
by progesterone itself. [28]. Osteogenic protein-1 (OP-1/
BMP-7), a member of the transforming growth factor
(TGF-ß) superfamily of proteins, reduced the secretion of
progesterone in cytotrophoblast cultures of first-trimester
and term placentas [29].
We demonstrate that hAFT and glycodelin A stimulate
secretion of progesterone in human trophoblast cells in a
dose-dependent manner. In a recent study we showed that
both glycoproteins express sialyl Lewis carbohydrate
structures and are able to block E-selectin [30].
Recently, it was demonstrated that human trophoblast
cells isolated from term placentas synthesize transferrin
[31]. This transferrin isolated from cytotrophoblast and
syncytiotrophoblast cells was demonstrated to be differ-
ent from both maternal and fetal serum transferrin. A
higher degree of sialylation and an increase in branching
was described in cytotrophoblast transferrin. This is in
agreement with our findings of the carbohydrate struc-
tures in hAFT, suggesting that hAFT was produced by the
trophoblast and secreted into the amniotic fluid and not
into maternal circulation. In addition, human serum
transferrin, isolated from pregnant women, does not con-
tain (·1–3)-fucosylated N-glycans [30]. Because hAFT
contains (·1–3)-fucosylated N-glycans, representing sialyl
LeX elements, it is able to bind to selectins as shown by
our previous study [30]. Human trophoblast cells express
L- and E-selectin [32, 33]. Therefore transferrin produced
by trophoblast cells may act in a paracrine or autocrine
fashion on trophoblasts and contribute to the amniotic
fluid protein pool. Serum transferrin even if it is isolated
from pregnant women does not contain (·1–3)-fucosyl-
ated N-glycans and therefore does not stimulate proges-
terone production in trophoblasts. Glycodelin A also con-
tains (·1–3)-fucosylated N-glycans, representing sialyl
LeX elements. In addition, we were able to show that mod-
erate and high concentrations of glycodelin A stimulate
the progesterone production of trophoblast cells. Stimula-
tion with hAFT elevated progesterone secretion. Surpris-
ingly, also low concentrations of hAFT increased proges-
terone values significantly. The hAFT concentrations
used in the experiments correspond with the transferrin
concentrations in amnion fluid in vivo [34] and are lower
than in human serum (factor 33.74). The low progester-
one stimulatory effect of hAFT compared to glycodelin A
correlates with our measurements on inhibition power of
both glycoproteins in E-selectin-mediated cell adhesion
[30]. Glycodelin A binds to E-selectin more efficiently
compared to hAFT, suggesting a glycosylation in glycode-
lin that is more suitable to bind to selectins. Because
hAFT and serum transferrin are only different in their
glycosylation [22] and hAFT in contrast to serum trans-
ferrin contains (·1–3)-fucosylated N-glycans, we assume
that glycoproteins with these structures are able to stimu-
late progesterone production in trophoblast cells.
In summary, in this study we could show that glycopro-
teins expressing sialyl Lewis carbohydrate structures stim-
ulate the progesterone production of trophoblast cells. In
combination with previous data [31] that demonstrate the
synthesis of differentially glycosylated transferrin by tro-
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phoblast cells, a paracrine or autocrine mechanism is sus-
pected. In addition, our results indicate that glycodelin A
may have paracrine effects in reproductive tissues and at
the maternal–trophoblast interface. The precise mecha-
nism of glycodelin A–trophoblast interaction is under
investigation.
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